ClearPoint Neuro Inc vs Cisco Systems Inc — how do they compare? ClearPoint Neuro Inc trades at $14.92 (market cap $444.14M), while Cisco Systems Inc trades at $121.25 (market cap $483.10B). The key difference: Cisco Systems Inc is far larger — about 1087.7× ClearPoint Neuro Inc's market cap, and Cisco Systems Inc pays a 1.37% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| CLPT | CSCO | |
|---|---|---|
Market Cap | $444.14M | $483.10B |
Sector | Health | Technology |
52-Week High | $29.60 | $130.00 |
52-Week Low | $8.66 | $66.20 |
Enterprise Value | $478.72M | $497.76B |
Volume | — | 22,887,319 |
Dividend Yield | — | 1.37% |
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $14.21, up 6.12% today, amid mixed technical signals and challenging fundamentals. The company reported Q2 2026 revenue growth but missed earnings expectations with a loss of $0.38 per share, continuing a trend of negative profitability. Despite 100% analyst buy ratings, financial metrics show significant losses with a net income margin of -81.76% and negative cash flow from operations of $30 million projected for 2026.
The investment case hinges on regulatory progress and partnership developments in neurotechnology, but substantial execution risks and persistent losses present headwinds. While analyst consensus remains bullish on long-term potential, current financial performance suggests cautious optimism is warranted until profitability improves.
Cisco Systems (CSCO) trades at $120.43, down 0.82% on the day, amid a bullish technical outlook and strong earnings beats. The stock shows robust fundamentals with a 64.33% gross margin and consistent quarterly EPS outperformance. Recent AI cybersecurity initiatives and partner expansions fuel positive sentiment, with a consensus price target of $133.25 implying upside potential.
The outlook remains favorable given AI-driven growth catalysts and solid cash flow, though elevated valuation ratios and competitive pressures pose risks. Analyst consensus leans bullish with 52% buy ratings, supporting a constructive view for investors seeking exposure to networking and cybersecurity trends.
Trailing returns across standard periods
Latest headlines on both assets
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →Cisco Systems, Inc. provides information technology and networking services. The Company offers enterprise network security, software development, data collaboration, cloud computing, and other related services. Cisco Systems serves customers in the United States.
Read more on CSCO →